Clinical trial
Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant…
NCT00186264 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186264 |
|---|---|
| Title | Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response? |
| Official title | Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response? |
| Lead sponsor | Stanford University, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | venlafaxine XR, hydrocortisone |
| Enrollment | 18 |
| Start date | Aug 1, 2002 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: